HHS Syndication Storefront

The HHS Syndication Storefront allows you to syndicate (import) content from many HHS websites directly into your own website or application. These services are provided by HHS free of charge.

Search Media Items


Filter results by:
spinner

Newest Syndicated Content

NCI

TCGA Research Network Publications

An up-to-date list of publications by The Cancer Genome Atlas, including analyses performed after the original cancer type-specific studies were completed.

Preview   0 Users liked this content.
NCI

Radioterapia de haz externo para el cáncer

La radioterapia de haz externo se usa para tratar muchos tipos de cáncer. Es un tratamiento local en donde una máquina enfoca la radiación al cáncer. Aprenda sobre los diferentes tipos de radioterapia de haz externo y qué esperar si recibe esta terapia.

Preview   0 Users liked this content.
NCI

TCGA Ethics & Policies

Ethics and research policies addresed by TCGA for conducting human genomics research.

Preview   0 Users liked this content.
NCI

Requests for TCGA Materials

TCGA cannot, under any circumstances, accommodate external requests for analytes or tissue materials.

Preview   0 Users liked this content.
NCI

Cancer Research Training Award (CRTA)

The Cancer Research Training Award (CRTA) is an NCI fellowship award with an “umbrella” appointment mechanism for fellowship programs within NCI divisions, offices, and centers. Learn more about CRTA at NCI.

Preview   0 Users liked this content.
NCI

Outcomes & Impact of The Cancer Genome Atlas

TCGA has changed our understanding of cancer, how research is conducted, how the disease is treated in the clinic, and more. Learn about the impact of the TCGA program.

Preview   0 Users liked this content.
NCI

Deterioro cognitivo en adultos con cánceres fuera del sistema nervioso central (PDQ®)–Versión para pacientes

gastric cancer  cognitive impairment 

Resumen de información revisada por expertos acerca del deterioro cognitivo en pacientes de cáncer en relación con el funcionamiento cognitivo normal y las intervenciones para tratar los cambios cognitivos.

Preview   0 Users liked this content.
NCI

TCGA Molecular Characterization Platforms

Descriptions and supporting materials for each of the sequencing platforms and other technologies used to generate the TCGA dataset.

Preview   0 Users liked this content.
NCI

TCGA's Study of Breast Lobular Carcinoma

TCGA's Study of Breast Lobular Carcinoma

Preview   0 Users liked this content.
NCI

TCGA Computational Tools

Some of the data processing, visualization, and other computational tools developed by TCGA network researchers and collaborators.

Preview   0 Users liked this content.
NCI

NAVIGATE: NCI and VA Interagency Group to Accelerate Trials Enrollment

The NAVIGATE program will make it easier for veterans to access promising new cancer treatments via clinical trials. This partnership between NCI and the VHA will increase the number of VA Medical Centers participating in and conducting NCI-supported cancer clinical trials.

Preview   0 Users liked this content.
NCI

Respondent Burden

The respondent burden for those participating in Intramural Continuing Umbrella of Research Experiences (iCURE).

Preview   0 Users liked this content.
NCI

Carryover Unobligated Funds

Carryover is the process by which unobligated funds remaining at the end of a budget period may be carried forward to cover allowable costs in the next budget period. Learn more about how to carryover NCI grants.

Preview   0 Users liked this content.
NCI

Collaboration and Team Science: A Field Guide

Collaboration and Team Science: A Field Guide provides insight into the practices of conducting collaborative work. Since its 2010 publication, the authors have worked and learned from teams and organizations all over the world. Learn from these experiences in the second edition of the Team Science Field Guide.

Preview   0 Users liked this content.
NCI

Advances in Pancreatic Cancer Research

Find highlights of promising research about the treatment of pancreatic cancer, including studies of stroma modifying drugs and immunotherapy combinations. Selected NCI-supported programs that address pancreatic cancer are also described.

Preview   0 Users liked this content.